TRIBASIC CALCIUM PHOSPHATE

TRIBASIC CALCIUM PHOSPHATE was reported 1541 times

TRIBASIC CALCIUM PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT MUSCLE NEOPLASM 1 0.0714
1 THALASSAEMIA ALPHA 1 0.0303
2 SEGMENTED HYALINISING VASCULITIS 1 0.0098
3 ANAL POLYP 1 0.0097
4 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
5 MULTIPLE CHEMICAL SENSITIVITY 1 0.0075
6 BLOOD ALDOSTERONE INCREASED 1 0.0057
7 GINGIVAL OPERATION 1 0.0045
8 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
9 REGURGITATION 14 0.0041
10 POSTPARTUM DEPRESSION 1 0.0039
11 BREAST DISORDER FEMALE 1 0.0039
12 EYELID OPERATION 1 0.0037
13 FACIAL WASTING 1 0.0037
14 PRODUCT IMPURITY 1 0.0036
15 VULVAL ULCERATION 1 0.0035
16 VITAMIN B12 DEFICIENCY 14 0.0035
17 MUMPS 1 0.0032
18 ALLERGY TO ARTHROPOD BITE 1 0.0031
19 DECREASED VIBRATORY SENSE 1 0.0029
20 HEMIHYPOAESTHESIA 1 0.0028
21 LUNG CYST 1 0.0025
22 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
23 TRANSFERRIN SATURATION DECREASED 1 0.0023
24 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
25 LIGAMENT PAIN 1 0.0019
26 SALIVARY GLAND ENLARGEMENT 1 0.0019
27 UTERINE INFECTION 1 0.0019
28 EYE INFECTION BACTERIAL 1 0.0018
29 COLON INJURY 1 0.0017
30 OXYGEN CONSUMPTION DECREASED 1 0.0017
31 PROLONGED LABOUR 1 0.0016
32 RECTAL FISSURE 1 0.0016
33 OROPHARYNGEAL DISCOMFORT 14 0.0015
34 C-REACTIVE PROTEIN DECREASED 1 0.0015
35 MAMMOGRAM ABNORMAL 1 0.0015
36 MACULAR HOLE 2 0.0015
37 KERATOACANTHOMA 1 0.0015
38 ANGULAR CHEILITIS 1 0.0014
39 PAINFUL DEFAECATION 1 0.0014
40 PEPTIC ULCER HAEMORRHAGE 1 0.0014
41 MYOFASCIAL PAIN SYNDROME 1 0.0014
42 BITE 1 0.0014
43 LIPIDS ABNORMAL 1 0.0014
44 OTITIS MEDIA ACUTE 1 0.0014
45 LEGAL PROBLEM 1 0.0014
46 OBSTRUCTIVE PANCREATITIS 1 0.0013
47 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
48 PENILE HAEMORRHAGE 1 0.0012
49 CARDIAC STRESS TEST ABNORMAL 1 0.0012
50 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
51 PERIORBITAL PAIN 1 0.0012
52 APTYALISM 1 0.0012
53 URGE INCONTINENCE 1 0.0011
54 EMOTIONAL POVERTY 2 0.0011
55 EXPOSURE VIA DIRECT CONTACT 1 0.0011
56 BENIGN BREAST NEOPLASM 1 0.0010
57 METASTASES TO PLEURA 1 0.0010
58 NAIL GROWTH ABNORMAL 1 0.0009
59 OPTIC NERVE INJURY 1 0.0009
60 BILE DUCT CANCER 1 0.0008
61 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
62 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
63 JOINT WARMTH 1 0.0008
64 TESTICULAR SWELLING 1 0.0008
65 ERUCTATION 15 0.0008
66 SINUS ARRHYTHMIA 1 0.0008
67 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
68 TONGUE DRY 1 0.0007
69 LIP BLISTER 2 0.0007
70 CLUMSINESS 2 0.0007
71 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
72 MENINGITIS BACTERIAL 1 0.0007
73 INVESTIGATION ABNORMAL 1 0.0007
74 COCCYDYNIA 1 0.0007
75 EPICONDYLITIS 1 0.0007
76 NEOPLASM SKIN 1 0.0006
77 SKIN ABRASION 3 0.0006
78 NASAL ULCER 1 0.0006
79 FOREIGN BODY SENSATION IN EYES 4 0.0006
80 PATHOLOGICAL GAMBLING 1 0.0006
81 VEIN RUPTURE 1 0.0006
82 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
83 DEAFNESS BILATERAL 1 0.0006
84 GAZE PALSY 1 0.0006
85 LEFT VENTRICULAR FAILURE 2 0.0006
86 SENSITIVITY OF TEETH 1 0.0006
87 BREAST DISCHARGE 1 0.0006
88 EMBOLIC STROKE 2 0.0006
89 FEAR OF DISEASE 1 0.0006
90 METASTATIC RENAL CELL CARCINOMA 1 0.0005
91 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
92 INJECTION SITE CELLULITIS 1 0.0005
93 BLOOD IRON INCREASED 1 0.0005
94 LIP DISORDER 1 0.0005
95 BILE DUCT OBSTRUCTION 1 0.0005
96 SPINAL CORD COMPRESSION 2 0.0005
97 JOINT CREPITATION 1 0.0005
98 CARDIAC DISCOMFORT 1 0.0005
99 LIPIDS INCREASED 1 0.0005
100 POLYCYTHAEMIA 1 0.0005
101 VASCULAR OCCLUSION 1 0.0005
102 CHAPPED LIPS 2 0.0005
103 PERIARTHRITIS 1 0.0004
104 EYELID DISORDER 1 0.0004
105 NEPHROGENIC ANAEMIA 2 0.0004
106 LACUNAR INFARCTION 1 0.0004
107 GASTROINTESTINAL OBSTRUCTION 1 0.0004
108 SLOW SPEECH 1 0.0004
109 BRONCHITIS CHRONIC 1 0.0004
110 HAEMATOLOGICAL INFECTION 1 0.0004
111 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
112 CARTILAGE INJURY 1 0.0004
113 OSTEITIS 1 0.0004
114 METASTASES TO PERITONEUM 1 0.0004
115 URINARY TRACT INFECTION BACTERIAL 1 0.0004
116 ENDODONTIC PROCEDURE 1 0.0004
117 PATHOLOGICAL FRACTURE 2 0.0004
118 RETINAL DISORDER 1 0.0004
119 WHITE BLOOD CELL DISORDER 1 0.0004
120 WEIGHT BEARING DIFFICULTY 1 0.0004
121 HEART RATE ABNORMAL 2 0.0004
122 NECK MASS 1 0.0004
123 CEREBRAL THROMBOSIS 1 0.0004
124 PERONEAL NERVE PALSY 2 0.0004
125 DUODENAL ULCER HAEMORRHAGE 1 0.0003
126 HYPERTONIC BLADDER 1 0.0003
127 VOMITING PROJECTILE 1 0.0003
128 EYE PAIN 19 0.0003
129 CREPITATIONS 1 0.0003
130 CEREBROVASCULAR DISORDER 1 0.0003
131 EMERGENCY CARE 1 0.0003
132 NECK PAIN 18 0.0003
133 BREAST CANCER RECURRENT 1 0.0003
134 POLYMYALGIA RHEUMATICA 1 0.0003
135 PLASMA CELL MYELOMA RECURRENT 1 0.0003
136 POSTURE ABNORMAL 1 0.0003
137 PHARYNGEAL SWELLING 3 0.0003
138 BREAST ENLARGEMENT 1 0.0003
139 SOMNAMBULISM 2 0.0003
140 HYPOGAMMAGLOBULINAEMIA 2 0.0003
141 NEOPLASM RECURRENCE 1 0.0003
142 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
143 VIITH NERVE PARALYSIS 1 0.0003
144 HAIR GROWTH ABNORMAL 2 0.0003
145 GRANULOMA 1 0.0003
146 TACHYPHRENIA 1 0.0003
147 LOGORRHOEA 1 0.0003
148 ASTHMATIC CRISIS 1 0.0003
149 BLOOD PHOSPHORUS DECREASED 1 0.0003
150 ALCOHOL USE 1 0.0003
151 IMPULSIVE BEHAVIOUR 1 0.0003
152 FACE INJURY 1 0.0003
153 SCAB 3 0.0003
154 TENDONITIS 4 0.0003
155 CONCUSSION 2 0.0003
156 SENSATION OF HEAVINESS 1 0.0003
157 EPIGASTRIC DISCOMFORT 1 0.0003
158 ORAL INFECTION 1 0.0003
159 WOUND SECRETION 1 0.0003
160 NAIL DISCOLOURATION 1 0.0003
161 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
162 FOREIGN BODY 1 0.0002
163 INTRACRANIAL ANEURYSM 1 0.0002
164 ORGAN FAILURE 1 0.0002
165 FUNGAL SKIN INFECTION 1 0.0002
166 ENURESIS 1 0.0002
167 NOCTURIA 3 0.0002
168 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
169 GOITRE 1 0.0002
170 HEMIPARESIS 4 0.0002
171 VITAMIN D DECREASED 2 0.0002
172 PRODUCT DISPENSING ISSUE 1 0.0002
173 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
174 TONGUE DISCOLOURATION 1 0.0002
175 PULMONARY FUNCTION TEST DECREASED 1 0.0002
176 ONYCHOMYCOSIS 1 0.0002
177 GROIN PAIN 2 0.0002
178 PARONYCHIA 1 0.0002
179 HAEMORRHAGIC ANAEMIA 1 0.0002
180 DYSPEPSIA 22 0.0002
181 INJECTION SITE PAPULE 1 0.0002
182 EAR DISORDER 1 0.0002
183 INCREASED TENDENCY TO BRUISE 2 0.0002
184 ARTHRITIS INFECTIVE 1 0.0002
185 GASTRITIS EROSIVE 1 0.0002
186 YELLOW SKIN 1 0.0002
187 PHOTOPHOBIA 4 0.0002
188 APHAGIA 1 0.0002
189 HUMERUS FRACTURE 1 0.0002
190 HORMONE LEVEL ABNORMAL 1 0.0002
191 NASAL POLYPS 1 0.0002
192 PANCREATIC DISORDER 1 0.0002
193 HYPERVOLAEMIA 1 0.0002
194 FLUID INTAKE REDUCED 1 0.0002
195 VEIN DISORDER 1 0.0002
196 VULVOVAGINAL PRURITUS 1 0.0002
197 HIP ARTHROPLASTY 3 0.0002
198 INITIAL INSOMNIA 2 0.0002
199 BASAL CELL CARCINOMA 3 0.0002
200 PRODUCT USE COMPLAINT 3 0.0002
201 IMPAIRED WORK ABILITY 4 0.0002
202 ANAL FISSURE 1 0.0002
203 PRODUCT RESIDUE PRESENT 1 0.0002
204 MUSCLE TIGHTNESS 3 0.0002
205 NORMAL NEWBORN 1 0.0002
206 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
207 DEAFNESS UNILATERAL 1 0.0002
208 HYPERKERATOSIS 1 0.0002
209 NERVE INJURY 2 0.0002
210 PERIORBITAL SWELLING 1 0.0002
211 GRANULOCYTOPENIA 1 0.0002
212 DERMATITIS CONTACT 2 0.0002
213 MICTURITION URGENCY 2 0.0002
214 EXERCISE TOLERANCE DECREASED 1 0.0002
215 PRODUCT SUBSTITUTION ISSUE 10 0.0002
216 SPINAL PAIN 2 0.0002
217 URINE ODOUR ABNORMAL 1 0.0002
218 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
219 LYMPHOCYTE COUNT DECREASED 3 0.0002
220 ENERGY INCREASED 1 0.0002
221 CATARACT OPERATION 1 0.0002
222 THIRST 3 0.0002
223 MUSCLE RIGIDITY 2 0.0002
224 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
225 SPINAL OPERATION 2 0.0002
226 TENDON RUPTURE 2 0.0002
227 GENERALISED OEDEMA 2 0.0002
228 SCREAMING 1 0.0002
229 PROCTALGIA 1 0.0002
230 HAEMOGLOBIN ABNORMAL 1 0.0002
231 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
232 JOINT STIFFNESS 4 0.0002
233 SKIN MASS 1 0.0001
234 QUALITY OF LIFE DECREASED 2 0.0001
235 PRODUCT LABEL ISSUE 1 0.0001
236 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
237 BLOOD TESTOSTERONE DECREASED 1 0.0001
238 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
239 ECCHYMOSIS 1 0.0001
240 ONYCHOCLASIS 1 0.0001
241 DROOLING 1 0.0001
242 LYMPHOEDEMA 1 0.0001
243 ABDOMINAL DISTENSION 15 0.0001
244 COORDINATION ABNORMAL 2 0.0001
245 BLOOD TEST ABNORMAL 2 0.0001
246 PULMONARY TOXICITY 1 0.0001
247 LYMPHOPENIA 2 0.0001
248 BALANCE DISORDER 12 0.0001
249 VISUAL FIELD DEFECT 1 0.0001
250 RASH PUSTULAR 1 0.0001
251 DYSSTASIA 4 0.0001
252 THERAPY CESSATION 7 0.0001
253 MELAENA 3 0.0001
254 LABORATORY TEST ABNORMAL 4 0.0001
255 CEREBRAL DISORDER 1 0.0001
256 ARTHROPOD BITE 1 0.0001
257 SKIN HAEMORRHAGE 2 0.0001
258 TOOTH DISORDER 3 0.0001
259 COLON CANCER 2 0.0001
260 HEART RATE IRREGULAR 3 0.0001
261 LACRIMATION INCREASED 4 0.0001
262 TENDON PAIN 1 0.0001
263 BLOOD COUNT ABNORMAL 2 0.0001
264 BOWEL MOVEMENT IRREGULARITY 1 0.0001
265 DISSOCIATION 1 0.0001
266 MUSCLE TWITCHING 3 0.0001
267 APHTHOUS ULCER 1 0.0001
268 GASTROINTESTINAL INFLAMMATION 1 0.0001
269 DRUG SCREEN POSITIVE 1 0.0001
270 FURUNCLE 1 0.0001
271 RENAL CYST 1 0.0001
272 BLOOD DISORDER 1 0.0001
273 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
274 MOVEMENT DISORDER 4 0.0001
275 FRUSTRATION TOLERANCE DECREASED 1 0.0001
276 MUSCLE DISORDER 1 0.0001
277 BLOOD POTASSIUM INCREASED 2 0.0001
278 POST PROCEDURAL INFECTION 1 0.0001
279 PRODUCT DOSE OMISSION 8 0.0001
280 ASPHYXIA 1 0.0001
281 POLYURIA 1 0.0001
282 ABNORMAL FAECES 1 0.0001
283 EYE IRRITATION 7 0.0001
284 ESCHERICHIA INFECTION 1 0.0001
285 PHOTOSENSITIVITY REACTION 2 0.0001
286 VIRAL INFECTION 4 0.0001
287 POLLAKIURIA 5 0.0001
288 BLOOD UREA INCREASED 2 0.0001
289 HYPERSENSITIVITY 22 0.0001
290 ANGER 4 0.0001
291 FLUSHING 12 0.0001
292 SKIN ULCER 3 0.0001
293 SPEECH DISORDER 6 0.0001
294 URINE OUTPUT DECREASED 1 0.0001
295 COLD SWEAT 2 0.0001
296 LUNG INFILTRATION 1 0.0001
297 RESPIRATORY RATE INCREASED 1 0.0001
298 GOUT 2 0.0001
299 PAIN OF SKIN 3 0.0001
300 END STAGE RENAL DISEASE 2 0.0001
301 NERVE COMPRESSION 1 0.0001
302 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
303 PERSONALITY CHANGE 1 0.0001
304 MIDDLE INSOMNIA 2 0.0001
305 HOT FLUSH 8 0.0001
306 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
307 PRODUCT PACKAGING ISSUE 1 0.0001
308 INTENTIONAL DOSE OMISSION 3 0.0001
309 MIGRAINE 10 0.0001
310 GAIT DISTURBANCE 20 0.0001
311 PRESCRIBED OVERDOSE 2 0.0001
312 PLASMA CELL MYELOMA 4 0.0001
313 SKIN FISSURES 2 0.0001
314 THERAPY CHANGE 1 0.0001
315 HOSPICE CARE 1 0.0001
316 LIGAMENT SPRAIN 1 0.0001
317 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
318 EMBEDDED DEVICE 1 0.0001
319 BLADDER DISORDER 1 0.0001
320 SALIVARY HYPERSECRETION 1 0.0001
321 APHASIA 3 0.0001
322 EMPHYSEMA 1 0.0001
323 VERTIGO 6 0.0001
324 DRY THROAT 1 0.0001
325 TOOTH ABSCESS 1 0.0001
326 BLINDNESS 4 0.0001
327 MUSCLE SPASMS 18 0.0001
328 MOBILITY DECREASED 7 0.0001
329 RIB FRACTURE 2 0.0001
330 TEMPERATURE INTOLERANCE 1 0.0001
331 VENTRICULAR EXTRASYSTOLES 1 0.0001
332 SWOLLEN TONGUE 3 0.0001
333 KNEE ARTHROPLASTY 2 0.0001
334 SCRATCH 1 0.0001
335 NEUROPATHY PERIPHERAL 9 0.0001
336 INCONTINENCE 1 0.0001
337 FULL BLOOD COUNT ABNORMAL 1 0.0001
338 RENAL PAIN 1 0.0001
339 MOOD SWINGS 3 0.0001
340 BREAST PAIN 1 0.0001
341 EPISTAXIS 7 0.0001
342 HEREDITARY ANGIOEDEMA 1 0.0001
343 BREAST CANCER METASTATIC 1 0.0001
344 POOR QUALITY SLEEP 2 0.0001
345 SKIN LACERATION 1 0.0001
346 BLOOD PRESSURE INCREASED 14 0.0001
347 INTENTIONAL PRODUCT MISUSE 8 0.0001
348 TOOTH FRACTURE 1 0.0001
349 FUNGAL INFECTION 3 0.0001
350 HYPERTENSIVE CRISIS 1 0.0001
351 GLOSSODYNIA 2 0.0001
352 OCULAR DISCOMFORT 1 0.0001
353 PARAESTHESIA 14 0.0001
354 BLOOD CALCIUM DECREASED 1 0.0001
355 IMPAIRED DRIVING ABILITY 1 0.0001
356 CHOLECYSTECTOMY 1 0.0001
357 INTERNAL HAEMORRHAGE 1 0.0001
358 HYPOAESTHESIA 13 0.0001
359 RENAL DISORDER 4 0.0001
360 BURNING SENSATION 6 0.0001
361 BLOOD IRON DECREASED 1 0.0001
362 CATARACT 5 0.0001
363 MACULAR DEGENERATION 1 0.0001
364 DEPRESSION 19 0.0001
365 WRIST FRACTURE 1 0.0001
366 LOCALISED INFECTION 2 0.0001
367 ABDOMINAL PAIN UPPER 17 0.0001
368 CRYING 3 0.0001
369 RESTLESSNESS 3 0.0001
370 FEELING HOT 5 0.0001
371 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
372 HYPERCALCAEMIA 1 0.0001
373 ABASIA 2 0.0001
374 HEART RATE INCREASED 8 0.0001
375 EYE SWELLING 3 0.0001
376 HAIR COLOUR CHANGES 1 0.0001
377 AGEUSIA 2 0.0001
378 VISION BLURRED 11 0.0001
379 INJECTION SITE DISCOLOURATION 1 0.0001
380 HALLUCINATION 6 0.0001
381 CHRONIC KIDNEY DISEASE 6 0.0001
382 PRODUCT COMPLAINT 2 0.0001
383 MUSCLE ATROPHY 1 0.0001
384 FLUID RETENTION 4 0.0001
385 INTRAOCULAR PRESSURE INCREASED 1 0.0001
386 SEIZURE 9 0.0001
387 RASH GENERALISED 2 0.0001
388 NODULE 1 0.0001
389 IMMUNE SYSTEM DISORDER 1 0.0001
390 TOOTH INFECTION 1 0.0001
391 PULMONARY CONGESTION 1 0.0001
392 OROPHARYNGEAL PAIN 7 0.0001
393 HAIR TEXTURE ABNORMAL 1 0.0001
394 FEAR 2 0.0001
395 THROAT TIGHTNESS 2 0.0001
396 PRODUCT TASTE ABNORMAL 1 0.0001
397 DRUG TOXICITY 1 0.0001
398 GINGIVAL BLEEDING 1 0.0001
399 PERIPHERAL COLDNESS 1 0.0001
400 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
401 CONTUSION 7 0.0001
402 ABNORMAL DREAMS 2 0.0001
403 ORAL DISCOMFORT 1 0.0001
404 CARPAL TUNNEL SYNDROME 1 0.0001
405 ALOPECIA 14 0.0001
406 PAIN IN EXTREMITY 21 0.0001
407 HEPATOCELLULAR INJURY 1 0.0001
408 MYELODYSPLASTIC SYNDROME 1 0.0001
409 ANOSMIA 1 0.0001
410 CONSTIPATION 15 0.0001
411 APATHY 1 0.0001
412 PALPITATIONS 8 0.0001
413 SURGERY 4 0.0001
414 CONFUSIONAL STATE 11 0.0001
415 ILLNESS 7 0.0001
416 LIVER DISORDER 3 0.0001
417 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
418 DYSGEUSIA 5 0.0001
419 GASTROINTESTINAL DISORDER 6 0.0001
420 FEELING ABNORMAL 16 0.0001
421 BLOOD POTASSIUM DECREASED 2 0.0001
422 HEPATIC FAILURE 2 0.0001
423 HYPOAESTHESIA ORAL 1 0.0001
424 TREMOR 11 0.0001
425 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
426 DRUG DISPENSING ERROR 1 0.0001
427 PHARYNGEAL OEDEMA 1 0.0001
428 PERIPHERAL SWELLING 10 0.0001
429 THYROID DISORDER 1 0.0001
430 MUSCULOSKELETAL CHEST PAIN 1 0.0001
431 EJECTION FRACTION DECREASED 1 0.0001
432 COGNITIVE DISORDER 3 0.0001
433 ARTHRITIS 5 0.0001
434 OCULAR HYPERAEMIA 3 0.0001
435 COMA 3 0.0001
436 MULTIPLE SCLEROSIS 3 0.0001
437 SCIATICA 1 0.0001
438 ABSCESS 1 0.0001
439 ARTHRALGIA 26 0.0001
440 WEIGHT INCREASED 14 0.0001
441 DRUG INTOLERANCE 6 0.0001
442 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
443 NIGHT SWEATS 2 0.0001
444 MUSCULAR WEAKNESS 7 0.0001
445 BACK DISORDER 1 0.0001
446 AMNESIA 4 0.0001
447 METASTASES TO BONE 1 0.0001
448 WEIGHT DECREASED 17 0.0001
449 INFLUENZA LIKE ILLNESS 5 0.0001
450 DRY EYE 3 0.0001
451 INSOMNIA 16 0.0001
452 SKIN DISORDER 2 0.0001
453 AGGRESSION 3 0.0001
454 CHILLS 7 0.0001
455 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
456 SKIN EXFOLIATION 5 0.0001
457 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
458 METRORRHAGIA 1 0.0001
459 MUSCULOSKELETAL DISCOMFORT 1 0.0001
460 MULTI-ORGAN FAILURE 1 0.0001
461 NIGHTMARE 2 0.0001
462 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
463 DIARRHOEA 37 0.0001
464 DEVICE USE ISSUE 1 0.0001
465 FALL 19 0.0001
466 MUSCULOSKELETAL STIFFNESS 5 0.0001
467 AMENORRHOEA 1 0.0001
468 PAIN 35 0.0001
469 HEART RATE DECREASED 2 0.0001
470 SLEEP DISORDER 4 0.0001
471 VISUAL IMPAIRMENT 7 0.0001
472 HEAD DISCOMFORT 1 0.0001
473 ASTHENIA 21 0.0001
474 DISTURBANCE IN ATTENTION 3 0.0001
475 TOOTHACHE 1 0.0001
476 OSTEOMYELITIS 1 0.0001
477 RESTLESS LEGS SYNDROME 1 0.0001
478 BONE DISORDER 1 0.0001
479 PANIC ATTACK 2 0.0001
480 SUICIDAL IDEATION 5 0.0001
481 PRODUCT DOSE OMISSION ISSUE 16 0.0001
482 HEADACHE 34 0.0001
483 BLOOD GLUCOSE ABNORMAL 1 0.0001
484 DIZZINESS 27 0.0001
485 ARTHROPATHY 3 0.0001
486 CONJUNCTIVITIS 1 0.0001
487 HEPATIC STEATOSIS 1 0.0001
488 THINKING ABNORMAL 1 0.0001
489 BLISTER 3 0.0001
490 BLOOD SODIUM DECREASED 1 0.0001
491 FOOT FRACTURE 1 0.0001
492 DYSPHAGIA 5 0.0001
493 BLOOD URINE PRESENT 1 0.0001
494 MUSCULOSKELETAL DISORDER 1 0.0001
495 FEELING JITTERY 1 0.0001
496 SLEEP APNOEA SYNDROME 1 0.0001
497 LETHARGY 3 0.0001
498 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
499 GLAUCOMA 1 0.0001
500 DECREASED APPETITE 12 0.0001
501 DYSTONIA 1 0.0001
502 DYSPHONIA 3 0.0001
503 NASAL CONGESTION 3 0.0001
504 MEMORY IMPAIRMENT 7 0.0001
505 UPPER LIMB FRACTURE 1 0.0001
506 THROMBOSIS 4 0.0000
507 JOINT SWELLING 6 0.0000
508 FULL BLOOD COUNT DECREASED 1 0.0000
509 PRODUCT PHYSICAL ISSUE 1 0.0000
510 STOMATITIS 3 0.0000
511 EXTRA DOSE ADMINISTERED 2 0.0000
512 PSORIATIC ARTHROPATHY 2 0.0000
513 DISCOMFORT 3 0.0000
514 OSTEOPOROSIS 2 0.0000
515 INJECTION SITE WARMTH 1 0.0000
516 TOOTH LOSS 1 0.0000
517 PULMONARY HYPERTENSION 1 0.0000
518 HAEMORRHAGE 5 0.0000
519 URTICARIA 8 0.0000
520 ABDOMINAL DISCOMFORT 8 0.0000
521 OSTEOARTHRITIS 2 0.0000
522 EATING DISORDER 1 0.0000
523 RETCHING 1 0.0000
524 RECTAL HAEMORRHAGE 2 0.0000
525 HYPOACUSIS 2 0.0000
526 RHINORRHOEA 3 0.0000
527 PRURITUS GENERALISED 1 0.0000
528 SEPTIC SHOCK 2 0.0000
529 MENTAL DISORDER 2 0.0000
530 PRODUCT PRESCRIBING ISSUE 1 0.0000
531 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
532 INFUSION RELATED REACTION 3 0.0000
533 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
534 THROAT IRRITATION 2 0.0000
535 ADVERSE DRUG REACTION 4 0.0000
536 CHROMATURIA 1 0.0000
537 SKIN IRRITATION 2 0.0000
538 TINNITUS 2 0.0000
539 SHOCK 1 0.0000
540 PERICARDIAL EFFUSION 1 0.0000
541 PNEUMONIA 14 0.0000
542 BACK PAIN 10 0.0000
543 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
544 SWELLING 4 0.0000
545 DRUG DOSE OMISSION 7 0.0000
546 PULMONARY EMBOLISM 4 0.0000
547 DISEASE RECURRENCE 2 0.0000
548 RASH ERYTHEMATOUS 2 0.0000
549 HEPATIC CANCER 1 0.0000
550 INTERSTITIAL LUNG DISEASE 2 0.0000
551 MENTAL IMPAIRMENT 1 0.0000
552 MYALGIA 7 0.0000
553 FIBROMYALGIA 1 0.0000
554 URINARY TRACT INFECTION 7 0.0000
555 AGITATION 3 0.0000
556 LUNG DISORDER 2 0.0000
557 INJECTION SITE URTICARIA 1 0.0000
558 OSTEONECROSIS OF JAW 1 0.0000
559 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
560 COVID-19 7 0.0000
561 ACNE 3 0.0000
562 ABDOMINAL PAIN LOWER 1 0.0000
563 CHEST DISCOMFORT 4 0.0000
564 PRURITUS 15 0.0000
565 MALAISE 17 0.0000
566 FATIGUE 30 0.0000
567 DIPLOPIA 1 0.0000
568 RESPIRATORY TRACT INFECTION 1 0.0000
569 NERVOUSNESS 2 0.0000
570 DEAFNESS 1 0.0000
571 MUSCULOSKELETAL PAIN 2 0.0000
572 NASOPHARYNGITIS 7 0.0000
573 DEPRESSED MOOD 2 0.0000
574 CHEST PAIN 7 0.0000
575 INJECTION SITE BRUISING 3 0.0000
576 EAR INFECTION 1 0.0000
577 DEHYDRATION 5 0.0000
578 BREAST CANCER FEMALE 1 0.0000
579 CARDIAC FAILURE CONGESTIVE 3 0.0000
580 PRODUCT USE ISSUE 7 0.0000
581 FREQUENT BOWEL MOVEMENTS 1 0.0000
582 DRY MOUTH 3 0.0000
583 RASH PRURITIC 2 0.0000
584 OEDEMA 2 0.0000
585 LIMB INJURY 1 0.0000
586 RASH 16 0.0000
587 MOOD ALTERED 1 0.0000
588 RESPIRATORY DISTRESS 1 0.0000
589 CONDITION AGGRAVATED 11 0.0000
590 VOMITING 17 0.0000
591 DIVERTICULITIS 1 0.0000
592 FEELING COLD 1 0.0000
593 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
594 INFLUENZA 4 0.0000
595 HAEMOPTYSIS 1 0.0000
596 DEMENTIA 1 0.0000
597 WOUND 1 0.0000
598 NAUSEA 28 0.0000
599 DYSPNOEA 20 0.0000
600 PAIN IN JAW 1 0.0000
601 HYPERSOMNIA 1 0.0000
602 PANCREATIC CARCINOMA 1 0.0000
603 INFECTION 5 0.0000
604 BONE PAIN 2 0.0000
605 ACUTE MYOCARDIAL INFARCTION 1 0.0000
606 URINARY INCONTINENCE 1 0.0000
607 DEVICE ISSUE 3 0.0000
608 SUICIDE ATTEMPT 2 0.0000
609 ILL-DEFINED DISORDER 2 0.0000
610 PLEURAL EFFUSION 2 0.0000
611 EPILEPSY 1 0.0000
612 ACUTE KIDNEY INJURY 5 0.0000
613 DRUG ADMINISTRATION ERROR 1 0.0000
614 ADVERSE EVENT 3 0.0000
615 HOSPITALISATION 5 0.0000
616 EMOTIONAL DISORDER 1 0.0000
617 LIMB DISCOMFORT 1 0.0000
618 FEMUR FRACTURE 1 0.0000
619 NERVOUS SYSTEM DISORDER 1 0.0000
620 BLOOD GLUCOSE INCREASED 6 0.0000
621 ANXIETY 9 0.0000
622 CYSTITIS 1 0.0000
623 HYPOTHYROIDISM 1 0.0000
624 LOSS OF CONSCIOUSNESS 4 0.0000
625 HIP FRACTURE 1 0.0000
626 ATRIAL FIBRILLATION 3 0.0000
627 DEEP VEIN THROMBOSIS 2 0.0000
628 PSORIASIS 4 0.0000
629 IMPAIRED HEALING 1 0.0000
630 EYE DISORDER 1 0.0000
631 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
632 RENAL FAILURE 4 0.0000
633 VISUAL ACUITY REDUCED 1 0.0000
634 EXPIRED PRODUCT ADMINISTERED 1 0.0000
635 LIP SWELLING 1 0.0000
636 URINARY RETENTION 1 0.0000
637 GAIT INABILITY 1 0.0000
638 SOMNOLENCE 6 0.0000
639 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
640 PRODUCT QUALITY ISSUE 4 0.0000
641 HEPATIC ENZYME INCREASED 2 0.0000
642 SINUSITIS 3 0.0000
643 HAEMOGLOBIN DECREASED 3 0.0000
644 HAEMATURIA 1 0.0000
645 GASTRIC DISORDER 1 0.0000
646 DELIRIUM 1 0.0000
647 MYOCARDIAL INFARCTION 5 0.0000
648 HYPERKALAEMIA 1 0.0000
649 LYMPHADENOPATHY 1 0.0000
650 PLATELET COUNT DECREASED 3 0.0000
651 THERAPY INTERRUPTED 2 0.0000
652 CEREBRAL HAEMORRHAGE 1 0.0000
653 DRUG EFFECT INCOMPLETE 1 0.0000
654 HYPERGLYCAEMIA 1 0.0000
655 UNDERDOSE 2 0.0000
656 ACCIDENTAL OVERDOSE 1 0.0000
657 DYSURIA 1 0.0000
658 INJECTION SITE MASS 1 0.0000
659 DYSARTHRIA 1 0.0000
660 DYSPNOEA EXERTIONAL 1 0.0000
661 ASTHMA 3 0.0000
662 INTESTINAL OBSTRUCTION 1 0.0000
663 COLITIS 1 0.0000
664 DISEASE PROGRESSION 3 0.0000
665 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
666 ABNORMAL BEHAVIOUR 1 0.0000
667 DISORIENTATION 1 0.0000
668 OEDEMA PERIPHERAL 3 0.0000
669 DYSKINESIA 1 0.0000
670 NEUTROPHIL COUNT DECREASED 1 0.0000
671 LUNG NEOPLASM MALIGNANT 1 0.0000
672 RHABDOMYOLYSIS 1 0.0000
673 WITHDRAWAL SYNDROME 1 0.0000
674 CEREBROVASCULAR ACCIDENT 4 0.0000
675 RENAL FAILURE ACUTE 1 0.0000
676 DEVICE DISLOCATION 1 0.0000
677 ANGIOEDEMA 1 0.0000
678 TACHYCARDIA 2 0.0000
679 DRY SKIN 3 0.0000
680 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
681 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
682 SKIN DISCOLOURATION 1 0.0000
683 HYPOKALAEMIA 1 0.0000
684 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
685 COUGH 6 0.0000
686 CARDIAC DISORDER 2 0.0000
687 COLORECTAL CANCER 1 0.0000
688 PRODUCTIVE COUGH 1 0.0000
689 BLOOD GLUCOSE DECREASED 1 0.0000
690 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
691 PYREXIA 7 0.0000
692 LEUKOPENIA 1 0.0000
693 CELLULITIS 1 0.0000
694 ECZEMA 1 0.0000
695 PANCREATITIS 1 0.0000
696 BRADYCARDIA 1 0.0000
697 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
698 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
699 HAEMATOCHEZIA 1 0.0000
700 ANAPHYLACTIC REACTION 1 0.0000
701 MEDICATION ERROR 1 0.0000
702 SEPSIS 2 0.0000
703 FLATULENCE 1 0.0000
704 RHEUMATOID ARTHRITIS 2 0.0000
705 DEATH 15 0.0000
706 HERPES ZOSTER 1 0.0000
707 ABDOMINAL PAIN 4 0.0000
708 IRRITABILITY 1 0.0000
709 THERAPEUTIC RESPONSE DECREASED 1 0.0000
710 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
711 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
712 INJECTION SITE ERYTHEMA 2 0.0000
713 ANAEMIA 3 0.0000
714 HYPERHIDROSIS 2 0.0000
715 SWELLING FACE 1 0.0000
716 BLOOD PRESSURE DECREASED 1 0.0000
717 NEOPLASM MALIGNANT 1 0.0000
718 HYPOTENSION 3 0.0000
719 INJECTION SITE PRURITUS 1 0.0000
720 INJECTION SITE REACTION 1 0.0000
721 DRUG INEFFECTIVE 19 0.0000
722 DEVICE MALFUNCTION 1 0.0000
723 HYPERTENSION 3 0.0000
724 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
725 SKIN BURNING SENSATION 1 0.0000
726 OFF LABEL USE 12 0.0000
727 BRONCHITIS 1 0.0000
728 DIABETES MELLITUS 1 0.0000
729 DRUG INTERACTION 2 0.0000
730 CARDIAC FAILURE 1 0.0000
731 PROSTATE CANCER 1 0.0000
732 CARDIAC ARREST 1 0.0000
733 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
734 DRUG WITHDRAWAL SYNDROME 1 0.0000
735 BREAST CANCER 1 0.0000
736 SYNCOPE 1 0.0000
737 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
738 ERYTHEMA 2 0.0000
739 OVERDOSE 2 0.0000
740 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
741 INCORRECT DOSE ADMINISTERED 2 0.0000
742 NEUTROPENIA 1 0.0000
743 TOXICITY TO VARIOUS AGENTS 1 0.0000
744 NO ADVERSE EVENT 1 0.0000
745 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
746 INJECTION SITE PAIN 1 0.0000